Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

Interparfums Extends Roberto Cavalli License Until 2046

Interparfums has extended its exclusive worldwide fragrance license for Roberto Cavalli and Just Cavalli by 20 years, keeping the partnership in place through December 31, 2046.

The company said it has managed the Cavalli license since 2023 and has used that period to expand the brand’s fragrance lineup. Interparfums said it introduced new extensions and collections tied to existing pillars including Uomo, Just Cavalli and Marbleous, and broadened the brand’s reach in both women’s and men’s markets.

In 2025, Interparfums launched Serpentine, which it described as its first blockbuster for the brand. The company said the launch “exceeded our expectations” and helped open new opportunities in key markets around the world.

Interparfums said Roberto Cavalli has become one of the fastest-growing brands in its portfolio, with gains in shelf space and consumer attention across major markets.

The Roberto Cavalli and Just Cavalli fragrance lines will continue to be run through Interparfums Italia Srl, the company’s wholly owned Italian subsidiary. Interparfums said that subsidiary is based in Florence with management in Paris.

Interparfums said its licensed portfolio now includes 20 brands, among them Coach, Jimmy Choo, Lacoste, Moncler, Montblanc, Oscar de la Renta and Van Cleef & Arpels, with products sold in more than 120 countries. As a result of these announcements, the company's shares have moved -0.34% on the market, and are now trading at a price of $110.36. For the full picture, make sure to review INTERPARFUMS INC's 8-K report.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS